The DOI matches its Crossref record.
Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension
Abstract
The application of chemometric methods to 1H NMR spectroscopic data has been documented for pathophysiological processes. In this study we show the application of 1H NMR-based metabonomics to investigate a relationship between serum metabolic profiles and hypertension. Although hypertension can be defined using blood pressure measurements, the underlying aetiology and metabolic effects are not so readily identified. Serum profiles for patients with low/normal systolic blood pressure (SBP < or = 130 mm Hg; n = 28), borderline SBP (131-149 mm Hg; n = 19) and high SBP (> or = 150 mm Hg; n = 17) were acquired using 1H NMR spectroscopy. Orthogonal signal correction followed by principal components analysis were applied to these NMR data in order to facilitate interpretation, and the resulting chemometric models were validated using Soft Independent Modelling of Class Analogy. Using 1H NMR-based metabonomics, it was possible to distinguish low/ normal SBP serum samples from borderline and high SBP samples. Borderline and high SBP samples, however, were indiscriminate from each other. Our preliminary results showed that there was a relationship between serum metabolic profiles and blood pressure which, in part, was due to lipoprotein particle composition differences between the samples. Furthermore, our results indicated that serum pathology associated with blood pressure is apparent at SBP values > 130 mm Hg, which the WHO and ISH currently define as the limit between normal and high-normal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gut microbiota dysbiosis contributes to the development of hypertension
Li, J., Zhao, F., Wang, Y., Chen, J., Tao, J., Tian, G., Wu, S., Liu, W., Cui, Q., Geng, B., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0222-x · Cited by 1,685
“Moreover, our findings revealed indiscriminate metabolic profilings between pHTN and HTN, consistent with a previous report that the serum spectral profiles of the hosts were similar at a stage of SBP ≥130 mmHg and at SBP ≥150 mmHg [53].”
ResultMetabolomics-based methods for early disease diagnostics
Gowda, G. N., Zhang, S., Gu, H., Asiago, V., Shanaiah, N., & Raftery, D. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.5.617 · Cited by 692
Metabolomics: A Global Biochemical Approach to Drug Response and Disease
Kaddurah-Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094715 · Cited by 670
Metabonomics in Toxicology: A Review
Robertson, D. G. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi102 · Cited by 541
Metabolomics in human nutrition: opportunities and challenges
Gibney, M. J., Walsh, M. C., Brennan, L., Roche, H. M., German, B. J., & van Ommen, B. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.82.3.497 · Cited by 452
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Bogdanov, M., Matson, W. R., Wang, L., Matson, T., Saunders-Pullman, R., Bressman, S. S., & Beal, M. F. (2008) · Brain · doi:10.1093/brain/awm304 · Cited by 401
High‐Throughput Metabolomics by 1D NMR
Vignoli, A., Ghini, V., Meoni, G., Licari, C., Takis, P. G., Tenori, L., Turano, P., & Luchinat, C. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804736 · Cited by 365
Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics
Odunsi, K., Wollman, R. M., Ambrosone, C. B., Hutson, A., McCann, S. E., Tammela, J., Geisler, J. P., Miller, G., Sellers, T., Cliby, W., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.20651 · Cited by 317
NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations
Emwas, A.-H. M., Salek, R. M., Griffin, J. L., & Merzaban, J. (2013) · Metabolomics · doi:10.1007/s11306-013-0524-y · Cited by 296
Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases
Kaddurah-Daouk, R., & Krishnan, K. R. R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.174 · Cited by 293
Walsh, M. C., Brennan, L., Malthouse, J. P. G., Roche, H. M., & Gibney, M. J. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.3.531 · Cited by 291
Holmes, E., Tsang, T. M., Huang, J. T.-J., Leweke, F. M., Koethe, D., Gerth, C. W., Nolden, B. M., Gross, S., Schreiber, D., Nicholson, J. K., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030327 · Cited by 290
Self-citationOMICS-driven biomarker discovery in nutrition and health
Kussmann, M., Raymond, F., & Affolter, M. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.02.014 · Cited by 286
Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
Quinones, M. P., & Kaddurah-Daouk, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.019 · Cited by 284
Metabolomics as a tool for cardiac research
Griffin, J. L., Atherton, H., Shockcor, J., & Atzori, L. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.138 · Cited by 278
Nutritional Metabonomics: Applications and Perspectives
Rezzi, S., Ramadan, Z., Fay, L. B., & Kochhar, S. (2007) · Journal of Proteome Research · doi:10.1021/pr060522z · Cited by 269
Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia
Kaddurah-Daouk, R., McEvoy, J., Baillie, R. A., Lee, D., Yao, J. K., Doraiswamy, P. M., & Krishnan, K. R. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002000 · Cited by 262
Metabolite profiling of fecal water extracts from human colorectal cancer
Monleón, D., Morales, J. M., Barrasa, A., López, J. A., Vázquez, C., & Celda, B. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1345 · Cited by 186
Nikolic, S. B., Sharman, J. E., Adams, M. J., & Edwards, L. M. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000168 · Cited by 79
Gürdeniz, G., Kristensen, M., Skov, T., & Dragsted, L. O. (2012) · Metabolites · doi:10.3390/metabo2010077 · Cited by 61
Machine learning integration of multimodal data identifies key features of blood pressure regulation
Louca, P., Tran, T. Q. B., Toit, C. D., Christofidou, P., Spector, T. D., Mangino, M., Suhre, K., Padmanabhan, S., & Menni, C. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104243 · Cited by 37
Peng, J., Cai, S., Wang, L., Zhao, N., Zhang, T.-J., Chen, Z.-X., & Meng, F.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090416 · Cited by 8
Metadata
- Authors
- Brindle, J. T., Nicholson, J. K., Schofield, P. M., Grainger, D. J., & Holmes, E.
- Venue
- The Analyst
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2002-12-17
- Volume
- 128
- Issue
- 1
- Pages
- 32-36
- ISSN
- 0003-2654 (ISSN-L)
- 1364-5528
- OpenAlex
- W2132624776
- Cited by
- 191
- References
- 0
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.